Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of […] Continue reading -> Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Noma Survivors Demand that WHO Lists Disease as NTD 25/05/2022 Maayan Hoffman A team of health professionals and Noma survivors called on the World Health Organization on Tuesday to list the deadly infection of the mouth and face as a neglected tropical disease (NTD) so that it can receive the attention it needs to be eradicated. “We hope that we can bring global attention to this disease […] Continue reading -> More Reliable Funding for WHO, Slow Progress on Pandemic Reform & Ukraine Controversy – What to Watch at the World Health Assembly 20/05/2022 Elaine Ruth Fletcher More stable funding for WHO, but only incremental progress on reforms in global pandemic response are expected out of the upcoming World Health Assembly, where member states also will debate and discuss over two dozen other critical health issues that don’t always make the headlines. The 75th World Health Assembly, WHO’s annual meeting of member […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer’s Antiviral Drug May Have Potential as Long COVID Treatment 06/06/2022 Maayan Hoffman Scientists and doctors are beginning to eye Paxlovid, the antiviral medicine developed by Pfizer to protect vulnerable people from severe disease, as a potential treatment for lingering COVID-19 symptoms after single patients report that the medicine has helped to reduce their symptoms. Long COVID affects as many as one in five people infected by the […] Continue reading -> Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Noma Survivors Demand that WHO Lists Disease as NTD 25/05/2022 Maayan Hoffman A team of health professionals and Noma survivors called on the World Health Organization on Tuesday to list the deadly infection of the mouth and face as a neglected tropical disease (NTD) so that it can receive the attention it needs to be eradicated. “We hope that we can bring global attention to this disease […] Continue reading -> More Reliable Funding for WHO, Slow Progress on Pandemic Reform & Ukraine Controversy – What to Watch at the World Health Assembly 20/05/2022 Elaine Ruth Fletcher More stable funding for WHO, but only incremental progress on reforms in global pandemic response are expected out of the upcoming World Health Assembly, where member states also will debate and discuss over two dozen other critical health issues that don’t always make the headlines. The 75th World Health Assembly, WHO’s annual meeting of member […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press […] Continue reading -> Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Noma Survivors Demand that WHO Lists Disease as NTD 25/05/2022 Maayan Hoffman A team of health professionals and Noma survivors called on the World Health Organization on Tuesday to list the deadly infection of the mouth and face as a neglected tropical disease (NTD) so that it can receive the attention it needs to be eradicated. “We hope that we can bring global attention to this disease […] Continue reading -> More Reliable Funding for WHO, Slow Progress on Pandemic Reform & Ukraine Controversy – What to Watch at the World Health Assembly 20/05/2022 Elaine Ruth Fletcher More stable funding for WHO, but only incremental progress on reforms in global pandemic response are expected out of the upcoming World Health Assembly, where member states also will debate and discuss over two dozen other critical health issues that don’t always make the headlines. The 75th World Health Assembly, WHO’s annual meeting of member […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Launches Initiative to Share Medicines with Low Income Countries 26/05/2022 Editorial team Pfizer will provide all of its current and future patent-protected medicines and vaccines available in the United States and the European Union on a not-for-profit basis to 45 lower-income countries where some 1.5 billion people live. However, critics have questioned whether the announcement has been timed to undermine a possible waiver on intellectual property for […] Continue reading -> Noma Survivors Demand that WHO Lists Disease as NTD 25/05/2022 Maayan Hoffman A team of health professionals and Noma survivors called on the World Health Organization on Tuesday to list the deadly infection of the mouth and face as a neglected tropical disease (NTD) so that it can receive the attention it needs to be eradicated. “We hope that we can bring global attention to this disease […] Continue reading -> More Reliable Funding for WHO, Slow Progress on Pandemic Reform & Ukraine Controversy – What to Watch at the World Health Assembly 20/05/2022 Elaine Ruth Fletcher More stable funding for WHO, but only incremental progress on reforms in global pandemic response are expected out of the upcoming World Health Assembly, where member states also will debate and discuss over two dozen other critical health issues that don’t always make the headlines. The 75th World Health Assembly, WHO’s annual meeting of member […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Noma Survivors Demand that WHO Lists Disease as NTD 25/05/2022 Maayan Hoffman A team of health professionals and Noma survivors called on the World Health Organization on Tuesday to list the deadly infection of the mouth and face as a neglected tropical disease (NTD) so that it can receive the attention it needs to be eradicated. “We hope that we can bring global attention to this disease […] Continue reading -> More Reliable Funding for WHO, Slow Progress on Pandemic Reform & Ukraine Controversy – What to Watch at the World Health Assembly 20/05/2022 Elaine Ruth Fletcher More stable funding for WHO, but only incremental progress on reforms in global pandemic response are expected out of the upcoming World Health Assembly, where member states also will debate and discuss over two dozen other critical health issues that don’t always make the headlines. The 75th World Health Assembly, WHO’s annual meeting of member […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Reliable Funding for WHO, Slow Progress on Pandemic Reform & Ukraine Controversy – What to Watch at the World Health Assembly 20/05/2022 Elaine Ruth Fletcher More stable funding for WHO, but only incremental progress on reforms in global pandemic response are expected out of the upcoming World Health Assembly, where member states also will debate and discuss over two dozen other critical health issues that don’t always make the headlines. The 75th World Health Assembly, WHO’s annual meeting of member […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One In Three People Globally Need Assistive Technologies; ‘Stunning Disparity’ In Access 16/05/2022 Aishwarya Tendolkar From wheelchairs to memory aids, over 2.5 billion people in the world today need at least one assistive device either for communication, vision, mobility, as well as for certain cognitive functions, like memory aids. And the number is set to rise to 3.5 billion people by 2050 due to an ageing population and the prevalence […] Continue reading -> WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Chief Hopes for “Workable Compromise” on TRIPS Waiver by June; US Signs Deal to Share COVID Vaccine Know-How with WHO 12/05/2022 Raisa Santos & Elaine Ruth Fletcher The United States National Institute of Health (NIH) has finalized an agreement with WHO’s COVID-19 patent sharing facility (C-TAP) to share the patent rights on 11 government-funded coronavirus medicine and vaccine technologies – in what is perhaps the most significant agreement to date with WHO to share closely-guarded pharma know-how. The announcement was made today […] Continue reading -> Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna Seeks Dismissal in US Court of COVID-19 Vaccine Patent Infringement Lawsuit By Arbutus, Genevant 11/05/2022 Aishwarya Tendolkar Moderna has filed a brief in the United States District Court for the District of Delaware seeking the dismissal of a patent infringement lawsuit that pertains to the production and sale of its COVID-19 mRNA vaccine Spikevax. The lawsuit against the U.S-based pharmaceutical giant was filed by Arbutus Biopharma Corporation and Genevant Sciences, which had […] Continue reading -> Posts navigation Older postsNewer posts